🇺🇸 FDA
Pipeline program

TBA-354

TBA-354-CL-001

Phase 1 small_molecule completed

Quick answer

TBA-354 for Tuberculosis is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 2 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Tuberculosis
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials